According to Zhitong Finance App, Yongtai Bio-B (06978) issued an announcement. On October 28, 2026 (before the trading period), the company signed a placement agreement with the placement agent. According to this, the placement agent has agreed (as the company's placement agent) to place the placement shares (up to 124 million new shares) according to the best effort basis, and the placement price will not be less than HK$0.300 per placement share (the final placement price will be agreed between the Company and the placement agent on or before the completion date).

The maximum number of shares placed is equivalent to 20% of the total number of shares currently issued at the date of this announcement and approximately 16.67% of the total number of issued shares after all allotments and the expansion of the issued shares. The minimum placement price of HK$0.300 is approximately 13.04% off of the closing price of HK$0.345 per share as reported on the Stock Exchange on the last trading day.

Assuming that the shares are placed at the minimum placement price, the total minimum proceeds from the placement will be approximately HK$37.1 million. The minimum net proceeds from placement transactions (after deducting commissions and other related expenses) are estimated to be approximately HK$36.1 million. It is anticipated that the full net proceeds from the placement will be used to supplement the Group's research and development products and as its general working capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.